# Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

> **NCT04225052** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 34 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** YHP1903
- **DRUG:** Champix

## Key facts

- **NCT ID:** NCT04225052
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-19
- **Primary completion:** 2020-01-08
- **Final completion:** 2020-01-14
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2020-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04225052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04225052, "Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04225052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*